These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 31927030

  • 21. Falstatin, a cysteine protease inhibitor of Plasmodium falciparum, facilitates erythrocyte invasion.
    Pandey KC, Singh N, Arastu-Kapur S, Bogyo M, Rosenthal PJ.
    PLoS Pathog; 2006 Nov; 2(11):e117. PubMed ID: 17083274
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Falcipains, Plasmodium falciparum cysteine proteases as key drug targets against malaria.
    Teixeira C, Gomes JR, Gomes P.
    Curr Med Chem; 2011 Nov; 18(10):1555-72. PubMed ID: 21428877
    [Abstract] [Full Text] [Related]

  • 29. BDA-410: a novel synthetic calpain inhibitor active against blood stage malaria.
    Li X, Chen H, Jeong JJ, Chishti AH.
    Mol Biochem Parasitol; 2007 Sep; 155(1):26-32. PubMed ID: 17583361
    [Abstract] [Full Text] [Related]

  • 30. Therapeutic Targeting and Role of Cysteine Proteases in the Life Cycle of Malaria Parasite.
    Uddin A, Ara A, Thaer Abdulhameed H, Gupta S, Arora S, Singh S, Abid M.
    Curr Med Chem; 2024 Aug 23. PubMed ID: 39185645
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Comparative genome-wide analysis and evolutionary history of haemoglobin-processing and haem detoxification enzymes in malarial parasites.
    Ponsuwanna P, Kochakarn T, Bunditvorapoom D, Kümpornsin K, Otto TD, Ridenour C, Chotivanich K, Wilairat P, White NJ, Miotto O, Chookajorn T.
    Malar J; 2016 Jan 29; 15():51. PubMed ID: 26821618
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Biosynthesis, localization, and processing of falcipain cysteine proteases of Plasmodium falciparum.
    Dahl EL, Rosenthal PJ.
    Mol Biochem Parasitol; 2005 Feb 29; 139(2):205-12. PubMed ID: 15664655
    [Abstract] [Full Text] [Related]

  • 36. Distinct and stage specific nuclear factors regulate the expression of falcipains, Plasmodium falciparum cysteine proteases.
    Sunil S, Chauhan VS, Malhotra P.
    BMC Mol Biol; 2008 May 14; 9():47. PubMed ID: 18477411
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Blocking Plasmodium falciparum development via dual inhibition of hemoglobin degradation and the ubiquitin proteasome system by MG132.
    Prasad R, Atul, Kolla VK, Legac J, Singhal N, Navale R, Rosenthal PJ, Sijwali PS.
    PLoS One; 2013 May 14; 8(9):e73530. PubMed ID: 24023882
    [Abstract] [Full Text] [Related]

  • 39. Structure-activity relationships for inhibition of cysteine protease activity and development of Plasmodium falciparum by peptidyl vinyl sulfones.
    Shenai BR, Lee BJ, Alvarez-Hernandez A, Chong PY, Emal CD, Neitz RJ, Roush WR, Rosenthal PJ.
    Antimicrob Agents Chemother; 2003 Jan 14; 47(1):154-60. PubMed ID: 12499184
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.